Peptide Mapping GLP-1 Peptides is critical because GLP-1 analogs often contain structural modifications that directly influence their biological activity and stability
Clinical trial protocols studied retatrutide as a standalone treatment
Drafting the work or revising: N.K., M.T., S.S., H.J
In published preclinical work, KPV has been studied for inhibiting NF-B activation in intestinal epithelial cells, with one widely cited study showing PepT1-mediated transport into colonic cells as part of its anti-inflammatory mechanism in mouse colitis models (Dalmasso et al., Gastroenterology , 2008)
doi: 10.3389/fcdhc.2023.1293926 Received 13 September 2023 Accepted 16 November 2023 Published 08 December 2023 Volume 4 - 2023 Edited by Azra Durak-Nalbantic, Clinical Center University of Sarajevo, Bosnia and Herzegovina Reviewed by Edin Begic, Sarajevo School of Science and Technology, Bosnia and Herzegovina Updates Copyright 2023 Ferhatbegovi, Mri and Maci-Dankovi
Alterations of the gut microbiota in patients with severe chronic heart failure